1. 92 Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of SABR-COMET. (October 2019) Authors: Qu, Melody; Chen, Yujie; Zaric, Gregory; Senan, Suresh; Olson, Robert; Harrow, Stephen; John-Baptiste, Ava; Gaede, Stewart; Mulroy, Liam; Schellenberg, Devin; Senthi, Sashendra; Swaminath, Anand; Kopek, Neil; Liu, Mitchell; Warner, Andrew; Rodrigues, George; Palma, David; Louie, Alexander Journal: Radiotherapy and oncology Issue: Volume 139(2019)Supplement 1 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lung cancer symptom appraisal among people with chronic obstructive pulmonary disease: A qualitative interview study. Issue 4 (12th February 2019) Authors: Cunningham, Yvonne; Wyke, Sally; Blyth, Kevin G.; Rigg, Douglas; Macdonald, Sara; Macleod, Una; Harrow, Stephen; Robb, Kathryn A.; Whitaker, Katriina L. Journal: Psycho-oncology Issue: Volume 28:Issue 4(2019) Page Start: 718 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 91 Quality of Life Outcomes After Stereotactic Ablative Radiotherapy (SABR) Versus Standard of Care Palliative Treatments: A Secondary Analysis of the SABR-COMET Randomized Trial. (October 2019) Authors: Olson, Robert; Senan, Suresh; Harrow, Stephen; Gaede, Stewart; Louie, Alexander; Haasbeek, Niels; Mulroy, Liam; Lock, Michael; Rodriques, George; Yaremko, Brian; Schellenberg, Devin; Ahmad, Belal; Griffioen, Gwendolyn; Senthi, Sashendra; Swaminath, Anand; Kopek, Neil; Liu, Mitchell; Moore, Karen;... Journal: Radiotherapy and oncology Issue: Volume 139(2019)Supplement 1 Page Start: S41 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. 23: Cost-Effectiveness of Sabr in Oligometastatic Cancer: An Economic Analysis Based on Long-Term Results of the SABR-Comet Randomized Trial. (October 2021) Authors: Qu, Melody; Chen, Yujie; Zaric, Gregory; Senan, Suresh; Olson, Robert; Harrow, Stephen; John-Baptiste, Ava; Gaede, Stewart; Mulroy, Liam; Schellenberg, Devin; Senthi, Sashendra; Swaminath, Anand; Kopek, Neil; Liu, Mitchell; Warner, Andrew; Rodrigues, George; Palma, David; Louie, Alexander Journal: Radiotherapy and oncology Issue: Volume 163(2021)Supplement 1 Page Start: S13 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 62: Optimal Management of Radiation Pneumonitis: Preliminary Findings of an International Delphi Consensus Study. (October 2021) Authors: Voruganti, Indu; Cunningham, Cicely; McLeod, Lorraine; Harrow, Stephen; Louie, Alexander Journal: Radiotherapy and oncology Issue: Volume 163(2021)Supplement 1 Page Start: S29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Thymoma: a single centre, 10-year retrospective review. (March 2022) Authors: Cooper, Amy; Evans, Tamasin; Phillips, Iain; Harrow, Stephen; Leach, James; Tufail, Aisha; Campbell, Sorcha; Maclennan, Kirsty Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. CONCORDE: a phase Ib platform study of novel agents in combination with conventional radiotherapy in non-small cell lung cancer (NSCLC). (March 2022) Authors: Horne, Ashley; Ali, Aaisha; Brown, Sarah; Butterworth, Karl; Chalmers, Anthony; Clipson, Alexandra; Collinson, Fiona; Dive, Caroline; Faivre-Finn, Corinne; Forster, Martin; Franks, Kevin; Gilbert, Alexandra; Hanna, Gerry; Hannaway, Nicola; Harrow, Stephen; Hartley, John; Hiley, Crispin; Jones, Ro... Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S69 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Gross tumour volume predicts survival and correlates with pre-treatment serum albumin concentration in patients with stage III non-small cell lung cancer treated with chemo-radiotherapy. (March 2022) Authors: Killean, Angus; Fenner, Florence; Stares, Mark; Evans, Tamasin; Maclennan, Kirsty; Tufail, Aisha; Campbell, Sorcha; Harrow, Stephen; McLaren, Duncan; Phillips, Iain Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Biomarkers of systemic inflammation predict survival in stage III non-small cell lung cancer treated with chemoradiotherapy. (March 2022) Authors: Langley, Benjamin; Leach, James; Fenner, Florence; Killean, Angus; Barrie, Colin; Maclennan, Kirsty; Campbell, Sorcha; Evans, Tamasin; Tufail, Aisha; Harrow, Stephen; McMenemy, Maria; MacKean, Melanie; Phillips, Iain; Stares, Mark Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S53 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Adjuvant durvalumab post-chemoradiotherapy in stage III non-small cell lung cancer: experience from the Edinburgh Cancer Centre. (March 2022) Authors: Yan, Xiangfei; Price, Gareth; Raynes, George; Stares, Mark; Evans, Tamasin; Campbell, Sorcha; Tufail, Aisha; MacLennan, Kirsty; Barrie, Colin; MacKean, Melanie; Harrow, Stephen; Phillips, Iain Journal: Lung cancer Issue: Volume 165(2022)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗